Research Article

The Antileukemia Activity of Natural Product HQ17(3) Is Possibly Associated with Downregulation of miR-17-92 Cluster

Figure 1

Viability for leukemia cells treated with HQ17(3). K562, Molt-4, Ramos, and U937 were treated with various doses of HQ17(3) for 24 h. The cells were then subjected to viability assay using a CellQuanti-Blue kit. The viability of blank is designated to be 100%. The experiments were conducted in triplicate. Means ± SD are shown.